Migraine Pathophysiology: Role of Vasodilation

Vasodilation (widening of blood vessels) is a key component of migraine pathophysiology, particularly in the trigeminovascular system:

  • Activation of trigeminal nerve endings around meningeal vessels → release of CGRP, substance P, neurokinin A.
  • These neuropeptides cause vasodilation of meningeal arteries and plasma protein extravasation (neurogenic inflammation).
  • Dilated vessels mechanically stimulate perivascular trigeminal afferents → sustained pain signaling to thalamus and cortex.
  • Triptans/ergots constrict vessels via 5-HT1B/1D agonism; gepants block CGRP receptors without vasoconstriction.

Modern Understanding

Vasodilation is not the sole cause. Migraine originates in brainstem/hypothalamic nuclei (migraine generator) → cortical spreading depression (aura) → trigeminovascular activation. Vasodilation amplifies and sustains pain but is downstream of central initiation.

Clinical Relevance

  • Explains throbbing quality (pulsatile distension).
  • Guides drug development (triptans, gepants, ditans).
  • Contraindicates vasoconstrictors in vascular disease.

Migraine - Related Articles